|
GMPS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.549790E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.269400E-01 |
| Normal-vs-Stage2 |
3.328800E-01 |
| Normal-vs-Stage3 |
8.175500E-02 |
| Normal-vs-Stage4 |
4.877800E-01 |
| Stage1-vs-Stage2 |
8.832000E-01 |
| Stage1-vs-Stage3 |
3.765800E-01 |
| Stage1-vs-Stage4 |
8.312400E-01 |
| Stage2-vs-Stage3 |
6.470200E-01 |
| Stage2-vs-Stage4 |
7.750400E-01 |
| Stage3-vs-Stage4 |
4.170000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.789600E-02 |
| Normal-vs-AfricanAmerican |
2.593400E-01 |
| Normal-vs-Asian |
6.487500E-02 |
| Caucasian-vs-AfricanAmerican |
1.912200E-02 |
| Caucasian-vs-Asian |
5.548200E-01 |
| AfricanAmerican-vs-Asian |
3.049600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.363000E-01 |
| Normal-vs-Female |
1.666620E-01 |
| Male-vs-Female |
9.865200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.732400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.180400E-02 |
| Normal-vs-Age(61-80Yrs) |
6.800200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.786000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.396100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.003800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.580400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.512300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.350400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.645600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.908600E-01 |
| Classical-VS-Follicular |
7.421200E-01 |
| Classical-VS-Other |
1.113200E-01 |
| Classical-VS-Normal |
4.264400E-01 |
| Tall-VS-Follicular |
5.849800E-01 |
| Tall-VS-Other |
2.437200E-01 |
| Tall-VS-Normal |
1.553580E-01 |
| Follicular-VS-Other |
2.373800E-01 |
| Follicular-VS-Normal |
3.455600E-01 |
| Other-VS-Normal |
3.129600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.277500E-02 |
| Normal-vs-N1 |
2.005600E-02 |
| N0-vs-N1 |
2.677000E-01 |
|
|
